84 related articles for article (PubMed ID: 1466683)
1. [Histologic variants of drug-induced toxicoderma].
Thomine E
Ann Pathol; 1992; 12(4-5):268-75. PubMed ID: 1466683
[No Abstract] [Full Text] [Related]
2. Necrotizing vasculitis due to gefitinib (Iressa).
Fernández-Guarino M; Ryan AM; Pérez-García B; Gónzalez-López C; Olasolo PJ
Int J Dermatol; 2007 Aug; 46(8):890-1. PubMed ID: 17651185
[No Abstract] [Full Text] [Related]
3. Urticarial vasculitis due do infliximab.
Goulão J; Cunha H; Anes I; Bártolo E; Furtado C; Serrano P; Brandão FM
J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):882-3. PubMed ID: 18462298
[No Abstract] [Full Text] [Related]
4. Chemotherapy and keratinocytes.
Henry LB; Horn TD
J Cutan Pathol; 2002 Nov; 29(10):575-8. PubMed ID: 12453293
[No Abstract] [Full Text] [Related]
5. Sebaceous glands as the primary target of EGFR-inhibitors in the development of papulopustular eruption.
Takata T; Tarutani M; Zouboulis CC; Sano S
J Dermatol Sci; 2012 May; 66(2):165-8. PubMed ID: 22440861
[No Abstract] [Full Text] [Related]
6. Atypical Painful Purpuric Cutaneous Nodules With Ibrutinib.
Marcaillou M; Stéphanie D; Marion B; Julien S; Christophe B
Am J Dermatopathol; 2020 Dec; 42(12):1012-1014. PubMed ID: 32675466
[No Abstract] [Full Text] [Related]
7. Bortezomib-associated cutaneous vasculitis.
Garcia-Navarro X; Puig L; Fernández-Figueras MT; Dalmau J; Roe E; Alomar A
Br J Dermatol; 2007 Oct; 157(4):799-801. PubMed ID: 17635511
[No Abstract] [Full Text] [Related]
8. Enalapril induced normocomplementemic urticarial vasculitis.
Koregol S; Naidu V; Rao S; Ankad BS
Indian J Dermatol Venereol Leprol; 2015; 81(1):73-4. PubMed ID: 25566910
[No Abstract] [Full Text] [Related]
9. New histopathologic findings in drug eruptions.
Fitzpatrick JE
Dermatol Clin; 1992 Jan; 10(1):19-36. PubMed ID: 1530913
[TBL] [Abstract][Full Text] [Related]
10. Rituximab-induced serum sickness.
Schutgens RE
Br J Haematol; 2006 Oct; 135(2):147. PubMed ID: 16869826
[No Abstract] [Full Text] [Related]
11. Tocilizumab-associated cutaneous reactive endotheliomatosis in a patient with rheumatoid arthritis.
Wu CP; Hsieh CW; Chen DY; Lee BJ; Yang CS
Joint Bone Spine; 2015 Mar; 82(2):132-4. PubMed ID: 25553831
[No Abstract] [Full Text] [Related]
12. [A hydroxyurea-induced leg ulceration].
Lammintausta K; Mäkelä L; Remes K
Duodecim; 2001; 117(1):31-3. PubMed ID: 12092349
[No Abstract] [Full Text] [Related]
13. [Dermatologic reactions to amifostine].
Moreno Alvarez PJ; Madurga Sanz M
Farm Hosp; 2003; 27(3):200-1. PubMed ID: 12835824
[No Abstract] [Full Text] [Related]
14. Serious cutaneous reactions to amifostine.
Prescrire Int; 2003 Dec; 12(68):225. PubMed ID: 14986696
[No Abstract] [Full Text] [Related]
15. Morbilliform drug reaction with histologic features of pustular dermatosis associated with bryostatin-1.
Krejci-Manwaring JM; Bogle MA; Diwan HA; Duvic MA
J Drugs Dermatol; 2003 Oct; 2(5):557-61. PubMed ID: 14558406
[TBL] [Abstract][Full Text] [Related]
16. Histopathologic reactions to chemotherapeutic agents.
Fitzpatrick JE; Hood AF
Adv Dermatol; 1988; 3():161-83. PubMed ID: 2978953
[TBL] [Abstract][Full Text] [Related]
17. Imatinib-induced erythroderma mediated by an unusual non-dose-dependent mechanism.
Vano-Galvan S; Fernandez-Guarino M; Henriquez-Santana A; De Las Heras E; Calbacho M; Jaen P
Eur J Dermatol; 2007; 17(6):538-9. PubMed ID: 17951138
[No Abstract] [Full Text] [Related]
18. [Enalapril-induced vasculitis].
Ayani I; Martínez MJ; Lekuona I; Manrique P
Med Clin (Barc); 1991 Apr; 96(15):596. PubMed ID: 1828848
[No Abstract] [Full Text] [Related]
19. Hand-foot and stump syndrome to sorafenib.
Lai SE; Kuzel T; Lacouture ME
J Clin Oncol; 2007 Jan; 25(3):341-3. PubMed ID: 17235051
[No Abstract] [Full Text] [Related]
20. More on interferon-induced cutaneous necrosis.
Shinohara K
N Engl J Med; 1995 Nov; 333(18):1222; author reply 1223-4. PubMed ID: 7565992
[No Abstract] [Full Text] [Related]
[Next] [New Search]
